6.0
[]. Alexei Pushechnikov, et al. Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type and spinocerebellar ataxia type 3. J Am Chem Soc. 009 Jul ;3(8):9767-79.
[]. H Kinemuchi, et al. Inhibition of tissue-bound semicarbazide-sensitive amine oxidase by two haloamines, -bromoethylamine and 3-bromopropylamine. Arch Biochem Biophys. 00 Jan ;385():54-6.
[3]. M W Crankshaw, et al. Modification of cysteine. Curr Protoc Protein Sci. 00 May:Chapter 5:Unit5..
[4]. Qiang Chen, et al. Direct Pore Binding as a Mechanism for Isoflurane Inhibition of the Pentameric Ligand-gated Ion Channel ELIC. Sci Rep. 05 Sep 8:5:3833.
[5]. R A Jue, et al. Identification of cysteine residues alkylated with 3-bromopropylamine by protein sequence analysis. Anal Biochem. 993 Apr;0():39-44.
H35-H39-H335
P6-P64-P7-P80-P30+P35